denosumab
amgen,daiichi sankyo
['denosumab']
hip #bmd declines with antiresorptive first followed by #teriparatide applies to #alendronate and #denosumab consider using anabolic agent first dr felicia cosman #acr22 
Rheumatologist | Physician |  Portsmouth Hospitals University NHS Trust UK | Views my own | Re-tweets do not mean endorsement | Mainly clinical news/updates